Vivani Medical, Inc.
VANI
$1.15
-$0.04-3.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -6.44% | 42.94% | -22.09% | -30.93% | -5.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.30% | 3.91% | -11.69% | -18.88% | -5.67% |
| Operating Income | -5.30% | -3.91% | 11.69% | 18.88% | 5.67% |
| Income Before Tax | -4.36% | -0.40% | 10.93% | 17.93% | 4.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.36% | -0.40% | 10.93% | 17.93% | 4.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.36% | -0.40% | 10.93% | 17.93% | 4.42% |
| EBIT | -5.30% | -3.91% | 11.69% | 18.88% | 5.67% |
| EBITDA | -5.34% | -4.12% | 12.39% | 19.38% | 5.62% |
| EPS Basic | 8.04% | 10.75% | 18.07% | 24.28% | 7.07% |
| Normalized Basic EPS | 8.02% | 10.84% | 18.11% | 24.28% | 7.07% |
| EPS Diluted | 8.04% | 10.75% | 18.07% | 24.28% | 7.07% |
| Normalized Diluted EPS | 8.02% | 10.84% | 18.11% | 24.28% | 7.07% |
| Average Basic Shares Outstanding | 13.47% | 12.54% | 8.67% | 8.32% | 2.85% |
| Average Diluted Shares Outstanding | 13.47% | 12.54% | 8.67% | 8.32% | 2.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |